BioConsortia’s revolutionary R&D platform begins with its patented Advanced Microbial Selection (AMS) process which uses plants as the selection tool to generate libraries of beneficial plant-associated microbes.
Using an array of microbial and molecular tools, AMS isolates are screened for functional attributes creating a deep knowledge profile for each organism. Predictive models are then applied to identify the best isolates and consortia for multi-trait plant-based screening or for strain improvement using the latest gene editing tools.
